Avinger Inc (OQ:AVGR)

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
See Regulatory Filings on SEC
Company Contact
Address: 400 Chesapeake Dr
REDWOOD CITY CA 94063-4739
Tel: N/A
Website: avinger.com
IR: See website
Key People
James G. Cullen
Independent Chairman of the Board
Jeffrey M. Soinski
President, Chief Executive Officer, Director
Mark Weinswig
Chief Financial Officer
Himanshu N. Patel
Chief Technology Officer
Jaafer Golzar
Chief Medical Officer
Business Overview
Avinger, Inc., (Avinger) is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with the peripheral arterial disease (PAD). The Company manufactures and sells a suite of products in the United States and select international markets. Avinger's products include its Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.
Financial Overview
For the six months ended 30 June 2020, Avinger Inc revenues decreased 10% to $3.7M. Net loss applicable to common stockholders increased 3% to $11.8M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Other income net decrease from $569K (income) to $0K, Interest income decrease of 81% to $32K (income).
Employees: 81 as of Dec 31, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $22.27M as of Jun 30, 2020
Annual revenue (TTM): $8.70M as of Jun 30, 2020
EBITDA (TTM): -$17.78M as of Jun 30, 2020
Net annual income (TTM): -$23.32M as of Jun 30, 2020
Free cash flow (TTM): -$16.04M as of Jun 30, 2020
Net Debt Last Fiscal Year: N/A
Shares outstanding: 83,560,749 as of Aug 20, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.